van den Besselaar A M, Hermans J, van der Velde E A, Bussemaker-Verduyn den Boer E, van Halem-Visser L P, Jansen-Grüter R, Loeliger E A
J Biol Stand. 1986 Oct;14(4):305-17. doi: 10.1016/0092-1157(86)90018-1.
A number of commercial rabbit tissue thromboplastins used in oral anticoagulant control have been calibrated against the first International Reference Preparation for thromboplastins. This was done in a three-stage procedure by one laboratory, each stage representing a different level of thromboplastin comparability. The calibration model recently recommended by ICTH and ICSH was tested. This model proved to be suitable, although a statistically significant aberration was observed for some of the thromboplastins. The bias introduced by using the model in these non-ideal cases was small compared to the overall variation of the International Normalized Ratio, being the universal scale for reporting the prothrombin time during oral anticoagulant control. Batch-to-batch calibration using lyophilized pooled plasmas could be reliably performed for several commercial thromboplastins.
用于口服抗凝控制的多种市售兔组织凝血活酶已根据第一代国际凝血活酶参考制剂进行了校准。这是由一个实验室通过三个阶段的程序完成的,每个阶段代表不同水平的凝血活酶可比性。对国际血栓与止血学会(ICTH)和国际临床化学与检验医学联合会(ICSH)最近推荐的校准模型进行了测试。该模型被证明是合适的,尽管观察到某些凝血活酶存在统计学上显著的偏差。在这些非理想情况下使用该模型引入的偏差与国际标准化比值的总体变化相比很小,国际标准化比值是口服抗凝控制期间报告凝血酶原时间的通用尺度。对于几种市售凝血活酶,可以可靠地使用冻干混合血浆进行批次间校准。